Browse by Audience
MEMBER

Update Your Profile
Special Interest Groups (SIG)
Member Spotlights
IASP Connect
Join Now

RESEARCHER

PAIN
PAIN Reports
Pain Research Forum
Pain Researcher
Events

HEALTH CARE PROVIDER

Online Learning - PERC
Curricula
Graduate Opportunities
Treatment and Education Resources
Events

PATIENT & CAREGIVER

Resources for Living with Pain
Topic Pages
Free Videos
Events

PARTNER

Support IASP
Sponsor an Event
Become a Partner
Make a Donation

I am a
IASP Logo
Home I AM A Search Login

Papers of the Week

Home / Publications / Pain Research Forum / Papers of the Week / Tegaserod for the Treatment of Irritable Bowel Syndrome.

< BACK TO ARCHIVE


2020


Antiinflamm Antiallergy Agents Med Chem


http://www.ncbi.nlm.nih.gov/pubmed/31518227?dopt=Abstract


19


4

Tegaserod for the Treatment of Irritable Bowel Syndrome.

Authors

Tegaserod for the Treatment of Irritable Bowel Syndrome.
Madia V N, Messore A, Saccoliti F, Tudino V, De Leo A, De Vita D, Bortolami M, Scipione L, Pindinello I, Costi R, Di Santo R
Antiinflamm Antiallergy Agents Med Chem. 2020; 19(4):342-369.
PMID: 31518227.

Abstract

Tegaserod (Zelnorm®) is a 5-hydroxytryptamine (serotonin) type 4 receptor agonist for the treatment of hypomotility disorders of the lower gastrointestinal tract associated with the irritable bowel syndrome with constipation (IBS-C).
Read This Paper